Vision Treatment: Steroids for Traumatic Optic Neuropathy on Diagnostic Procedures and Therapy
Received Date: Jan 02, 2023 / Published Date: Jan 30, 2023
Abstract
Traumatic optic neuropathy (TON) is an exceptional vision-threatening clutter that can be caused by visual or head injury and is categorized into coordinate and backhanded TON. The overall incidence of
TON is 0.7–2.5%, and circuitous TON includes a higher predominance than direct TON. Discovery of an afferent pupillary deformity within the nearness of an intaglio globe in an understanding with visual or head injury with decreased visual keenness emphatically recommends TON. Be that as it may, afferent pupillary absconds may be troublesome to distinguish in patients who have gotten narcotics that cause pupillary choking and in those with reciprocal TON. Mechanical shearing of the optic nerve axons and wound rot due to prompt ischemia from harm to the optic nerve microcirculation and apoptosis of neurons may be a plausible component. The proper management of TON is disputable. High-dose corticosteroid treatment and decompression of the optic nerve give no additional benefit over perception alone. Intravenous erythropoietin may be a secure and productive treatment for patients with TON.
Citation: Rudy N (2023) Vision Treatment: Steroids for Traumatic Optic Neuropathyon Diagnostic Procedures and Therapy. Optom Open Access 8: 184. Doi: 10.4172/2476-2075.1000184
Copyright: © 2023 Rudy N. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1322
- [From(publication date): 0-2023 - Dec 22, 2024]
- Breakdown by view type
- HTML page views: 1117
- PDF downloads: 205